Abstract:Objective To explore the role of RNA-activated protein kinase-like endoplasmic reticulum kinase (PERK) pathway in the crosstalk of apoptosis and autophagy in human osteosarcoma HOS cells induced by pyropheophorbide-a methyl ester-mediated photodynamic therapy (MPPa-PDT) and investigate the mechanism by which PERK pathway inhibition enhances the sensitivity of the cells to MPPa-PDT. Methods We first observed the apoptotic morphology of human osteosarcoma HOS cells after MPPa-PDT using Hoechst 33258 staining. HOS cells were treated with MPPa-PDT alone or in combination with a PERK inhibitor (GSK2656157) or an autophagy inhibitor (Bafilomycin A1), and the changes in the expression of the proteins related to PERK pathway (PERK, p-PERK, ATF4, and CHOP), apoptosis (Cleaved caspase-3, Cleaved PARP) and autophagy (LC3-Ⅱ/LC3-Ⅰ and P62) were investigated using Western blotting; the changes in the expression of p-PERK was also examined using immunofluorescence assay. The cell apoptotic rates following the treatments were analyzed using flow cytometry. Results MPPa-PDT resulted in typical morphological changes of apoptosis (nuclear pyknosis and fragmentation) in HOS cells, and induced obvious autophagy and activation of PERK pathway. HOS cells treated with MPPa-PDT, compared with the control cells, showed significantly increased expression of Cleaved caspase-3, Cleaved PARP, LC3-Ⅱ/LC3-Ⅰ, p-PERK, ATF4 and CHOP and lowered expression of P62 and PERK; the cells exhibited stronger green fluorescence signals of p-PERK after MPPa-PDT treatment than the control cells. The application of GSK2656157 significantly blocked MPPa-PDT-induced increases in p-PERK, ATF4 and LC3-Ⅱ/LC3-Ⅰ expression levels, while treatment of the cells with GSK2656157 prior to MPPa-PDT enhanced the cell apoptosis and increased the expression levels of PERK, P62, Cleaved caspase-3 and Cleaved PARP. The cells with combined treatment with MPPa-PDT and GSK2656157 showed weaker green fluorescence signal of p-PERK than those with MPPa-PDT alone. Pretreatment of the cells with Bafilomycin A1 augmented the effects of MPPa-PDT to increase the expression levels of LC3-Ⅱ/LC3-Ⅰ, P62, Cleaved caspase-3 and Cleaved PARP and the apoptosis rate. Compared with the cells with combined MPPa-PDT and GSK2656157 treatment, the cells treated with MPPa-PDT and Bafilomycin A1 showed significantly increased levels of p-PERK, ATF4 and LC3-Ⅱ/LC3-Ⅰ and obviously lowered apoptotic rate and expression levels of PERK, Cleaved caspase-3 and Cleaved PARP. Conclusion The activation of PERK pathway induced by MPPa-PDT may mediate prosurvival autophagy and unfolded protein response, and blocking PERK pathway enhances the killing effect of MPPa-PDT in human osteosarcoma HOS cells.

Targeting X Box-Binding Protein-1 (XBP1) Enhances the Sensitivity of HOS Osteosarcoma Cells to Pyropheophorbide- Α Methyl Ester-Mediated Photodynamic Therapy.

Inhibition of PERK pathway enhances sensitivity of human osteosarcoma HOS cells induced to pyropheophorbide-a methyl ester-mediated photodynamic therapy

Paeoniflorin induces G2/M cell cycle arrest and caspase-dependent apoptosis through the upregulation of Bcl-2 X-associated protein and downregulation of B-cell lymphoma 2 in human osteosarcoma cells.

Targeting GRP78 enhances the sensitivity of HOS osteosarcoma cells to pyropheophorbide-α methyl ester-mediated photodynamic therapy via the Wnt/β-catenin signaling pathway

Targeting XPO6 Inhibits Prostate Cancer Progression and Enhances the Suppressive Efficacy of Docetaxel

Targeting PERK-ATF4-P21 axis enhances the sensitivity of osteosarcoma HOS cells to Mppα-PDT

Establishment And Characterization Of Human Osteosarcoma Cells Resistant To Pyropheophorbide-Alpha Methyl Ester-Mediated Photodynamic Therapy

Homologous targeting nanoparticles for enhanced PDT against osteosarcoma HOS cells and the related molecular mechanisms

Phenethyl Isothiocyanate Induces Oxidative Cell Death in Osteosarcoma Cells with Regulation on Mitochondrial Network, Function and Metabolism

Antitumor Effects and Mechanisms of Pyropheophorbide‑α Methyl Ester‑mediated Photodynamic Therapy Onthe Human Osteosarcoma Cell Line MG‑63

YAP knockdown in combination with ferroptosis induction increases the sensitivity of HOS human osteosarcoma cells to pyropheophorbide-α methyl ester-mediated photodynamic therapy

Overexpression of X-Box Binding Protein 1 (XBP1) Correlates to Poor Prognosis and Up-Regulation of PI3K/mTOR in Human Osteosarcoma

Overexpression of X-Box Binding Protein 1 (XBP1) Correlates to Poor Prognosis and Up-Regulation of PI3K/mTOR in Human Osteosarcoma.

Delivery of MutT Homolog 1 Inhibitor by Functionalized Graphene Oxide Nanoparticles for Enhanced Chemo-Photodynamic Therapy Triggers Cell Death in Osteosarcoma.

MTH1 inhibitor amplifies the lethality of reactive oxygen species to tumor in photodynamic therapy

Autophagy Inhibitor Enhance ZnPc/BSA Nanoparticle Induced Photodynamic Therapy by Suppressing PD-L1 Expression in Osteosarcoma Immunotherapy.

Capsaicin Enhanced the Efficacy of Photodynamic Therapy Against Osteosarcoma via a Pro‐Death Strategy by Inducing Ferroptosis and Alleviating Hypoxia

Bortezomib Sensitizes Human Osteosarcoma Cells to Adriamycin‐induced Apoptosis Through ROS‐dependent Activation of P‐eif2α/atf4/chop Axis

Intratibial osteosarcoma growth and pulmonary metastasis inhibition by HIPPO signaling pathway-induced photodynamic therapy

RhoA Enhances Osteosarcoma Resistance to MPPa-PDT Via the Hippo/YAP Signaling Pathway

Metabolism Of Reactive Oxygen Species In Osteosarcoma And Potential Treatment Applications